HIGHLIGHTS
- who: Tissue from the citation ID: ofac, . Efficacy and pharmacokinetics-pharmacodynamics of , in a rabbit model of cryptococcal meningoencephalitis Charles D. GiamberardinoJr., have published the research: only three doses which was sustained for week after the cessation of dosing, in the Journal: (JOURNAL) of October/20,/2022
- what: The authors aimed to compare the efficacy and safety between labeled and HLAD regimens of CAZ-AVI in CKD patients.
SUMMARY
Poster Abstracts. In the institution, higher than labeled adjusted dosing regimens (HLAD) has been used for the treatment of severe infections. Doses . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.